Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mazoyer

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
La Revue De Medecine Interne|March 19, 2018
[Vitamine K antagonists overdose: Physician adherence to the French guidelines]E Oliosi, O Pointeau, E Mazoyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?L Drouet, F Paolucci, N Pasqualini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 31, 2012
Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007N De Castro, E Mazoyer, R Porcher, et al.
Presse Medicale (Paris, France : 1983)|February 4, 1995
[Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?]M Karmochkine, J C Piette, E Mazoyer, et al.
European Journal of Biochemistry|November 26, 1990
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reactionE Mazoyer, S Lévy-Toledano, F Rendu, et al.
Annales Francaises D'Anesthesie Et De Reanimation|December 4, 2003
[Direct and indirect effects of epoietin alpha in an experimental model of thrombosis and bleeding in the rabbit]S Pham Tourreau, M Fattorutto, P Bonnin, et al.
Thrombosis Research|November 5, 2002
D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillationI Mahé, L Drouet, O Chassany, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Paracetamol: a haemorrhagic risk factor in patients on warfarinI Mahé, N Bertrand, L Drouet, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDSL Drouet, C Bal dit Sollier, M Cisse, et al.
Thrombosis and Haemostasis|May 1, 1994
Aprotinin could promote arterial thrombosis in pigs: a prospective randomized, blind studyC M Samama, E Mazoyer, P Bruneval, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
La Revue De Medecine Interne|March 19, 2018
[Vitamine K antagonists overdose: Physician adherence to the French guidelines]E Oliosi, O Pointeau, E Mazoyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?L Drouet, F Paolucci, N Pasqualini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 31, 2012
Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007N De Castro, E Mazoyer, R Porcher, et al.
Presse Medicale (Paris, France : 1983)|February 4, 1995
[Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?]M Karmochkine, J C Piette, E Mazoyer, et al.
European Journal of Biochemistry|November 26, 1990
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reactionE Mazoyer, S Lévy-Toledano, F Rendu, et al.
Annales Francaises D'Anesthesie Et De Reanimation|December 4, 2003
[Direct and indirect effects of epoietin alpha in an experimental model of thrombosis and bleeding in the rabbit]S Pham Tourreau, M Fattorutto, P Bonnin, et al.
Thrombosis Research|November 5, 2002
D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillationI Mahé, L Drouet, O Chassany, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Paracetamol: a haemorrhagic risk factor in patients on warfarinI Mahé, N Bertrand, L Drouet, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDSL Drouet, C Bal dit Sollier, M Cisse, et al.
Thrombosis and Haemostasis|May 1, 1994
Aprotinin could promote arterial thrombosis in pigs: a prospective randomized, blind studyC M Samama, E Mazoyer, P Bruneval, et al.
Pageof 4